Meyer Handelman CO Amgen Inc Transaction History

Meyer Handelman CO

$2.84 Billion
Q1 2025

A detailed history of Meyer Handelman CO transactions in Amgen Inc stock. As of the latest transaction made, Meyer Handelman CO holds 131,912 shares of AMGN stock, worth $38.1 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares

131,912

Previous 132,896 0.74%

Holding current value

$38.1 Million

Previous $34.6 Million 18.65%

% of portfolio

1.45%

Previous 1.21%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 08, 2025	SELL	$258.59 - $327.36 $254,452 - $322,122	-984 Reduced 0.74%	131,912 $41.1 Million
Q4 2024 Jan 14, 2025	BUY	$258.78 - $328.31 $187,097 - $237,368	723 Added 0.55%	132,896 $34.6 Million
Q3 2024 Oct 10, 2024	BUY	$309.38 - $337.38 $724,567 - $790,143	2,342 Added 1.8%	132,173 $42.6 Million
Q2 2024 Jul 16, 2024	BUY	$262.75 - $319.31 $2.29 Million - $2.78 Million	8,700 Added 7.18%	129,831 $40.6 Million
Q1 2024 Apr 11, 2024	BUY	$268.87 - $324.56 $3.63 Million - $4.38 Million	13,485 Added 12.53%	121,131 $34.4 Million
Q4 2023 Jan 17, 2024	SELL	$255.7 - $288.46 $944,811 - $1.07 Million	-3,695 Reduced 3.32%	107,646 $31 Million
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $1.07 Million - $1.33 Million	4,895 Added 4.6%	111,341 $29.9 Million
Q2 2023 Jul 21, 2023	BUY	$214.27 - $253.37 $224,983 - $266,038	1,050 Added 1.0%	106,446 $23.6 Million
Q1 2023 Apr 11, 2023	SELL	$225.79 - $275.2 $880,581 - $1.07 Million	-3,900 Reduced 3.57%	105,396 $25.5 Million
Q4 2022 Jan 25, 2023	SELL	$229.03 - $291.01 $1.95 Million - $2.47 Million	-8,500 Reduced 7.22%	109,296 $28.7 Million
Q3 2022 Oct 04, 2022	SELL	$224.46 - $253.15 $179,568 - $202,520	-800 Reduced 0.67%	117,796 $26.6 Million
Q4 2021 Jan 25, 2022	BUY	$198.88 - $227.6 $994,400 - $1.14 Million	5,000 Added 4.4%	118,596 $26.7 Million
Q3 2021 Nov 01, 2021	SELL	$212.27 - $248.7 $127,362 - $149,220	-600 Reduced 0.53%	113,596 $24.2 Million
Q2 2021 Aug 18, 2021	SELL	$233.58 - $259.14 $420,444 - $466,452	-1,800 Reduced 1.55%	114,196 $27.8 Million
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $621,348 - $724,080	2,800 Added 2.47%	115,996 $28.9 Million
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $459,807 - $547,548	2,125 Added 1.91%	113,196 $26 Million
Q3 2020 Oct 28, 2020	SELL	$234.65 - $260.95 $657,020 - $730,660	-2,800 Reduced 2.46%	111,071 $28.2 Million
Q2 2020 Jul 16, 2020	SELL	$197.81 - $242.74 $909,926 - $1.12 Million	-4,600 Reduced 3.88%	113,871 $26.9 Million
Q1 2020 Apr 22, 2020	BUY	$182.24 - $241.7 $272,995 - $362,066	1,498 Added 1.28%	118,471 $24 Million
Q4 2019 Jan 23, 2020	SELL	$189.21 - $243.2 $170,289 - $218,880	-900 Reduced 0.76%	116,973 $28.2 Million
Q3 2019 Oct 07, 2019	BUY	$174.11 - $208.62 $130,582 - $156,465	750 Added 0.64%	117,873 $22.8 Million
Q2 2019 Jul 23, 2019	BUY	$166.7 - $195.41 $833,500 - $977,050	5,000 Added 4.46%	117,123 $21.6 Million
Q1 2019 Apr 30, 2019	BUY	$180.87 - $203.88 $506,436 - $570,864	2,800 Added 2.56%	112,123 $20.6 Million
Q4 2018 Feb 05, 2019	SELL	$178.4 - $208.25 $294,360 - $343,612	-1,650 Reduced 1.49%	109,323 $21.3 Million
Q3 2018 Nov 06, 2018	SELL	$185.29 - $208.89 $251,623 - $283,672	-1,358 Reduced 1.21%	110,973 $23 Million
Q2 2018 Jul 30, 2018	BUY	$166.05 - $186.51 $91,327 - $102,580	550 Added 0.49%	112,331 $20.7 Million
Q1 2018 Apr 23, 2018	BUY	$169.43 - $198.0 $8,471 - $9,900	50 Added 0.04%	111,781 $19.1 Million
Q4 2017 Feb 07, 2018	BUY	$168.79 - $188.59 $143,471 - $160,301	850 Added 0.77%	111,731 $19.4 Million
Q3 2017 Oct 25, 2017	BUY	$167.29 - $191.0 $18.5 Million - $21.2 Million	110,881	110,881 $20.7 Million

Others Institutions Holding AMGN

# of Institutions

3,238

Shares Held

422M

Call Options Held

7.05M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meyer Handelman CO, based on Form 13F filings with the SEC.

News

Stay updated on Meyer Handelman CO with notifications on news.

Account

Meyer Handelman CO Amgen Inc Transaction History